ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AVXL Anavex Life Sciences Corporation

5.06
0.00 (0.00%)
Mar 27 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Anavex Life Sciences Corporation AVXL NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 5.06 19:00:00
Open Price Low Price High Price Close Price Previous Close
5.06
more quote information »

Recent News

Date Time Source Heading
3/26/202404:45PRNUSInvestors who lost money on Anavex Life Sciences..
3/25/202406:30GLOBEAnavex Life Sciences to Present at the 23rd Annual Needham..
3/22/202404:45PRNUSAVXL LAWSUIT ALERT: The Gross Law Firm Notifies Anavex Life..
3/18/202406:30GLOBEAnavex Life Sciences Initiates Placebo-Controlled U.S. Phase..
2/26/202406:30GLOBEAnavex Life Sciences to Present at the 44th Annual TD Cowen..
2/23/202405:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/23/202405:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/23/202405:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/23/202405:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/23/202405:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/07/202415:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2/07/202406:30GLOBEAnavex Life Sciences Reports Fiscal 2024 First Quarter..
2/01/202406:30GLOBEAnavex Life Sciences to Announce Fiscal 2024 First Quarter..
1/25/202416:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/24/202406:30GLOBEAnavex Life Sciences Reports Publication of ANAVEX®3-71 in..
1/16/202406:30GLOBEAnavex Life Sciences Announces U.S. Phase 2 Clinical Trial..
1/12/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202406:30GLOBEAnavex Life Sciences Announces Grant of U.S. Patent Covering..
1/03/202406:30GLOBEAnavex to Present at the 42nd Annual J.P. Morgan Healthcare..
1/02/202407:00GLOBEAnavex Life Sciences Provides an Update on Rett Syndrome..
12/20/202306:30GLOBEAnavex Announces First Entire Clinical Gene Pathway Data of..
12/19/202306:30GLOBEAnavex Received Agreement from the Committee for Medicinal..
11/27/202315:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11/27/202307:00GLOBEAnavex Life Sciences Reports Fiscal 2023 Year End Financial..
11/27/202305:29IHMARKETNEWSMonday’s Wall Street Highlights: Walmart, Disney, Lloyds..
11/24/202307:00GLOBEAnavex Life Sciences to Announce Fiscal 2023 Year End..
11/22/202307:00GLOBEAnavex Life Sciences Announces Grant of U.S. Patent Covering..
11/20/202307:00GLOBEAnavex Initiates Regulatory Submission of Oral Blarcamesine..
11/06/202307:00GLOBEAnavex Life Sciences Appoints Senior VP of Regulatory..
10/25/202307:00GLOBEAnavex Life Sciences Reports New Publication in Scientific..
9/14/202306:30GLOBEAnavex’s Phase 2b/3 Trial of Blarcamesine (ANAVEX®2-73) in..
9/12/202306:30GLOBEAnavex Announces Appointment of Dr. Marwan N Sabbagh, MD as..
8/08/202315:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202306:30GLOBEAnavex Life Sciences Reports Fiscal 2023 Third Quarter..
8/07/202306:30GLOBEAnavex Life Sciences Reports Publication of ANAVEX®3-71 in..
8/02/202306:30GLOBEAnavex Life Sciences to Present at the BTIG Virtual..
8/01/202306:30GLOBEAnavex Life Sciences to Announce Fiscal 2023 Third Quarter..
6/28/202306:30GLOBELong-term Clinical Study Demonstrates Disease Modifying..
6/27/202306:30GLOBEAnavex Life Sciences and Partex Group Announce Strategic..
6/20/202306:30GLOBEAnavex Life Sciences to Present at the H.C. Wainwright 4th..
6/15/202306:30GLOBEANAVEX®2-73 (blarcamesine) Receives Compassionate Use..
6/12/202306:30GLOBEAnavex Life Sciences Reports Publication in Medical Journal..
6/06/202306:30GLOBEAnavex Life Sciences Announces Completion of ANAVEX(®)2-73..
6/01/202306:30GLOBEANAVEX Announces Issuance of New U.S. Intellectual Property..
5/09/202306:30GLOBEAnavex Life Sciences Reports Fiscal 2023 Second Quarter..
5/02/202306:30GLOBEAnavex Life Sciences to Announce Fiscal 2023 Second Quarter..
5/01/202306:30GLOBEAnavex Life Sciences Announces Issuance of New U.S. Patent..
4/25/202306:30GLOBEAnavex Life Sciences to Present at the H.C. Wainwright..
4/10/202306:00GLOBEAnavex Life Sciences to Present at the 22nd Annual Needham..
3/30/202306:00GLOBEANAVEX®2-73 (Blarcamesine) Shows Clinical Benefit in..

Your Recent History

Delayed Upgrade Clock